Research interests

Getting the right message into the right cell.

Most of an intravenous LNP dose goes to the liver whether you want it to or not. Three stages of work on that — and on what it makes treatable.

How do you make the particle choose where it goes?

Antibody-directed T cell targeting
Conjugating antibodies to the LNP surface to steer particles onto T cells, generating CAR-T inside the patient rather than in a manufacturing suite.
Bioactive small molecule as a fifth component
Screening pharmacologically active small molecules as a fifth lipid component, so the additive carries its own pharmacology while also shifting expression and biodistribution.

LNP–RNA work assistant

Design, calculate, and document the workflow.

Practical tools for formulation design, experimental planning, measurement, and traceable LNP–RNA records.

Formulation · Screening · RiboGreen

Design lipid formulations, compare screening batches, and calculate RNA concentration and encapsulation efficiency.

Design · Conjugation · Purification · In vitro / in vivo

Record the complete targeted-LNP workflow, from formulation and conjugation to purification and biological studies.

IVT batches · RNA library · Experimental records

Track IVT batches and maintain a searchable mRNA library for downstream LNP studies.